"How It Works: 1) Screening. You will be tested onsite to determine your eligibility for each study that is conducted. Generally, each screening could last up to four hours. 2) Our team will review the Informed Consent with you, go over medical and medication history. This will in 3) Health Assessment. As a volunteer each study requires that a health assessment be performed to ensure that the participant’s physical evaluation meets the needs for a particular clinical test trial. 3) Participate. Help advance medical and scientific knowledge, carry out promising treatments for the future, and/or receive compensation for possibly improving someone else’s health. Questions? Recruiting@spauldingclinical.com Spaulding Clinical, First in Phase 1."

During the past decade, Spaulding Clinical Research conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 10 clinical trials were completed, i.e. on average, 20.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 9 clinical trials were completed. i.e. 34.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spaulding Clinical Research" #1 sponsor was "Food and Drug Administration (FDA)" with 10 trials, followed by "Wockhardt" with 5 trials sponsored, "The Medicines Company" with 4 trials sponsored, "RAI Services Company" with 3 trials sponsored and "Reata Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spaulding Clinical Research" #1 collaborator was "Spaulding Clinical Research LLC" with 19 trials as a collaborator, "Celerion" with 3 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Clinartis, LLC" with 2 trials as a collaborator and "Leiden University" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Spaulding Clinical Research" are "Healthy" (15 trials), "Healthy Volunteers" (9 trials), "Pharmacokinetics" (8 trials), "Healthy Subjects" (4 trials) and "Pharmacodynamics" (4 trials). Many other conditions were trialed in "Spaulding Clinical Research" in a lesser frequency.

Most popular intervention types in "Spaulding Clinical Research" are "Drug" (58 trials), "Other" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Moxifloxacin" (4 trials), "B19010-F" (2 trials), "CHS-1701" (2 trials) and "Isavuconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spaulding Clinical Research" are 61 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Spaulding Clinical Research". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Spaulding Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spaulding Clinical Research, 56 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".